PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Chip-based Oligonucleotide Synthesis market size is projected to grow from US$ 40.1 million in 2024 to US$ 149 million in 2030; it is expected to grow at a CAGR of 24.5% from 2024 to 2030. Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences. United States market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Chip-based Oligonucleotide Synthesis players cover Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. LPI (LP Information)' newest research report, the “Chip-based Oligonucleotide Synthesis Industry Forecast” looks at past sales and reviews total world Chip-based Oligonucleotide Synthesis sales in 2023, providing a comprehensive analysis by region and market sector of projected Chip-based Oligonucleotide Synthesis sales for 2024 through 2030. With Chip-based Oligonucleotide Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chip-based Oligonucleotide Synthesis industry. This Insight Report provides a comprehensive analysis of the global Chip-based Oligonucleotide Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chip-based Oligonucleotide Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chip-based Oligonucleotide Synthesis market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chip-based Oligonucleotide Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chip-based Oligonucleotide Synthesis. This report presents a comprehensive overview, market shares, and growth opportunities of Chip-based Oligonucleotide Synthesis market by product type, application, key players and key regions and countries. Segmentation by Type: Photochemical Method Electrochemical Method Inkjet Printing Method Segmentation by Application: Scientific Research Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries Segmentation by Type: Photochemical Method Electrochemical Method Inkjet Printing Method Segmentation by Application: Scientific Research Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Thermo Fisher GenScript LC Sciences Twist Bioscience Agilent Technologies Evonetix Dynegene Technologies LC-Bio Technologies Atantares BGI Genomics